Where does Noramco, Llc rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Noramco, Llc ranks #24,899 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Noramco, Llc hold?

Noramco, Llc holds 11 US utility patents granted between 2017 and 2021, spanning 8 technology areas.

What is Noramco, Llc's Innovation Score?

Noramco, Llc has an Innovation Score of 30.7 out of 100 (top 65% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Noramco, Llc focus on?

Noramco, Llc's top technology area is C07D (HETEROCYCLIC COMPOUNDS) with 10 patents. Grants appear in 8 CPC subclasses total.

Is Noramco, Llc's patent grant rate increasing or decreasing?

Noramco, Llc's recent grant velocity is -43% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Noramco, Llc's patents?

Noramco, Llc's patents average 20.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Noramco, Llc patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Noramco, Llc

USPTO PatentsView assignee record - 11 granted patents across 8 technology areas, recorded in grant years 2017–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07D (HETEROCYCLIC COMPOUNDS).

Compiled by PlainPatent · May 15, 2026

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Noramco ranks #24,899 of 50,000 tracked US assignees by granted-patent volume, with 11 patents across 8 technology areas.

#24,899
of 50,000 US assignees by volume: Top 65%
by Innovation Score (30.7/100): 20.2
avg claims per patent: -43%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R24899 · US Corporation #24,899 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 11 grants
MID-PACK #24,899/50,000
PHOTO-FINISH NIPPON MEDICAL SCHOO…
CPC-NARROW C07D · 8 areas
INNOV-THIN 30.7/100
CLAIMS-DENSE 20.2 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -43% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Nippon Medical School Foundation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Noramco · this assignee

31
3D Lighting Innovati… · lowest

7

What this shows Noramco's Innovation Score is 30.7/100 (top 65% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Noramco's grants concentrate

Noramco, Llc is a focused PatentsView assignee: 8 CPC subclasses with 90.9% of grants classified under C07D (HETEROCYCLIC COMPOUNDS). Peak complete grant year is 2018 (3 grants) versus a trough of 2 in 2017. By volume, Noramco sits between Nippon Medical School Foundation and Novita Pharmaceuticals, Inc..

Nippon Medical Sc…

11
Nippon Yusen

11
Nitto Pharmaceuti…

11
NMC

11
Northstar Battery

11
Novasight

11
Novatrans Group

11
Novita Pharmaceut…

11
Noramco ◀

11

What this shows Noramco holds 11 patents at rank #24,865, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Noramco

By rank, the assignees closest to #24,865 in granted patent volume.

Leaders in C07D (Heterocyclic Compounds)

Other assignees with the most granted patents in Noramco's primary technology class.

Noramco's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

31 Top 65% higher than 35% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Noramco, Llc patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	2	18.2%
2018	3	27.3%
2019	2	18.2%
2020	2	18.2%
2021	2	18.2%

Which technologies does Noramco, Llc patent most?

C07D - HETEROCYCLIC COMPOUNDS 10

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 2

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 2

C07C - ACYCLIC OR CARBOCYCLIC COMPOUNDS 2

C07B - GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR 2

B01J - CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS 1

C12P - FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 1

C12Y - ENZYMES 1

Top 8 of 8 technology areas

Where it ranks

Overall rank by patents

#24,899

of 50,000 tracked assignees

Innovation Score

30.7 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.